Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03514888 · ClinicalTrials.gov registry record · NA
HIPEC After Radical Cystectomy for High Risk Bladder Cancer
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03514888 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 7 participants.
The verdict
NCT03514888, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a non-randomized, non-blinded, pilot study administering hyperthermic intraperitoneal chemotherapy with Mitomycin-C in 10 men and women with muscle-invasive urothelial carcinoma of the bladder undergoing radical cystectomy with pelvic lymph node dissection who have risk factors for tumor recurrence.
Interventions
- PROCEDURE HIPEC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-04-19 |
| Est. Completion | 2023-05-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03514888
The ClinicalTrials.gov registry entry for NCT03514888 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HIPEC is the first listed.
NCT03514888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03514888 about?
NCT03514888 is a clinical study titled "HIPEC After Radical Cystectomy for High Risk Bladder Cancer". This is a non-randomized, non-blinded, pilot study administering hyperthermic intraperitoneal chemotherapy with Mitomycin-C in 10 men and women with muscle-invasive urothelial carcinoma of the bladder undergoing radical cystectomy with pelvic lymph node dissection who have risk factors for tumor rec...
What is the current status of trial NCT03514888?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-04-19. Estimated completion is 2023-05-23.
What interventions are being tested in trial NCT03514888?
The interventions under investigation include: HIPEC (PROCEDURE).
Who is sponsoring clinical trial NCT03514888?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.